In an experimental model of glioma, GL261 cell-based brain tumor-bearing mice pre-treated with CD25 mAb lived significantly longer than those bearing tumor and receiving control IgG antibody (El Andaloussi et al., 2006). This evidence concerns the gene IL2RA and brain neoplasm.